Timeline

Sylvain Baize
Head of Structure
30 Sep 2023
publication

Novel Antiviral Molecules against Ebola Virus Infection.

Read more
12 Sep 2023
publication

Hemostasis defects underlying the hemorrhagic syndrome caused by Mammarenaviruses in a cynomolgus macaque model.

Read more
11 Mar 2023
publication

Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys

Read more
01 Jan 2023
publication

A MOPEVAC multivalent vaccine induces sterile protection against New World arenaviruses in non-human primates.

Read more
01 Dec 2022
publication

Pathogenesis of recent Lassa virus isolates from lineages II and VII in cynomolgus monkeys.

Read more
21 Mar 2022
publication

Infection of Human Endothelial Cells with Lassa Virus Induces Early but Transient Activation and Low Type I IFN Response Compared to the Closely-Related Nonpathogenic Mopeia Virus.

Read more
09 Jun 2021
publication

A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains.

Read more
04 Jan 2021
publication

Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques.

Read more
02 Oct 2019
publication

Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot.

Read more
10 Jan 2019
publication

Immune parameters and outcomes during Ebola virus disease

Read more
27 Jul 2015
nrc

Haemorrhagic Fevers

Read more
21 Jul 2015
publication

Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement

Read more
19 Jul 2015
publication

Towards deep insight into Ebola virus disease

Read more
03 Jul 2015
project

Lassa fever

Read more
11 May 2015
team

Biology of Viral Emerging Infections

Read more
06 Feb 2015
publication

Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus

Read more
01 Jan 2015
publication

Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014

Read more
24 Nov 2014
publication

Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014

Read more
19 Nov 2014
publication

Ebola: should we consider influenza vaccination?

Read more
24 Sep 2014
publication

Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response

Read more
24 Sep 2014
publication

The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses

Read more
16 Apr 2014
publication

Emergence of Zaire Ebola virus disease in Guinea

Read more
27 Feb 2014
publication

Anjozorobe hantavirus, a new genetic variant of Thailand virus detected in rodents from Madagascar

Read more
09 Jan 2014
publication

Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever

Read more
25 Apr 2013
publication

Severe Seoul hantavirus infection in a pregnant woman, France, October 2012

Read more
05 Nov 2012
publication

Immune responses and Lassa virus infection

Read more
31 Aug 2011
publication

Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages

Read more
01 Jul 2011
publication

Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa

Read more
01 Oct 2010
publication

Towards broad protection against Ebolaviruses

Read more
20 Mar 2006
publication

Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages

Read more
01 Oct 2004
publication

Human macrophages, but not dendritic cells, are activated and produce alpha/beta interferons in response to Mopeia virus infection

Read more